Skip to main content
Clinical Trials/DRKS00024422
DRKS00024422
Not yet recruiting
未知

Prospective sample collection, data collection and analysis for the clinical applicability of immunome profiles in the discrimination and therapy monitoring of COVID-19 patients in different disease stages as well as for the identification and characterization of long-term consequences of a SARS-CoV-2 infection in comparison to patients with a respiratory non-COVID-19 viral infectious disease and healthy controls. - CoVImmun

Fraunhofer ITMP0 sites200 target enrollmentFebruary 19, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
U07.1
Sponsor
Fraunhofer ITMP
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fraunhofer ITMP

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for COVID\-19 patients:
  • positive testing for SARS\-CoV\-2 (PCR) or first presentation to the hospital if the test is known to be positive
  • Written consent to participate in the study by the patient or, in the case of patients unable to consent, by the legal representative
  • Moderate or severe COVID\-19 illness according to the WHO classification scheme:
  • o Patient group 1: Score 5\-7 (severe \- very severe)
  • o Patient group 2: Score 3 or 4 (moderate \- moderate\-severe)
  • Inclusion criteria for patients with respiratory non\-COVID\-19 viral infectious disease:
  • positive test for a respiratory non\-SARS\-CoV\-2 virus infection or first presentation in hospital if the test is known to be positive
  • negative test for SARS\-CoV\-2 within the last 2 weeks
  • Willingness and ability to give consent to participate in the study and clinical examinations and to adhere to the requirements of the study plan

Exclusion Criteria

  • Exclusion criteria for COVID\-19 patients:
  • Imprisoned or incapacitated patients
  • Severe anemia (Hb \<8mg / dl), which does not allow drawing blood regularly
  • Exclusion criteria for patients with a respiratory non\-COVID\-19 viral infectious disease:
  • Imprisoned or incapacitated patients
  • Severe anemia (Hb \<8mg / dl), which does not allow drawing blood regularly

Outcomes

Primary Outcomes

Not specified

Similar Trials